Hope for rare brain disease: new drug aims to delay death or paralysis
Disease control
Recruiting now
This study tests a drug called leriglitazone in adult men with cerebral adrenoleukodystrophy (cALD), a rare and serious brain disease. The goal is to see if the drug can delay death or the need for permanent breathing support compared to a placebo. About 40 men who cannot or choo…
Phase: PHASE3 • Sponsor: Minoryx Therapeutics, S.L. • Aim: Disease control
Last updated Apr 25, 2026 18:57 UTC